CIITA基因敲除Hela细胞
货号:
EDJ-KQ23263
物种:
人
细胞名称:
HeLa
基因名称:
CIITA
基因ID:
4261
规格:
1×10⁶cells
CIITA基因敲除细胞Hela是由艾迪基因优化的CRISPR/Cas9编辑而成,采用Sanger测序法验证敲除,保证单克隆,活性良好。
| 货号 | EDJ-KQ23263 |
|---|---|
| 产品名称 | CIITA Knockout Hela Cell Line |
| 细胞 | Hela |
| Cellosaurus ID | CVCL_0030 |
| 细胞别名 | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| 基因 | CIITA |
| 基因ID | |
| 基因别名 | C2TA|CIITAIV|MHC2D1|MHC2TA|NLRA |
| 摘要 |
This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
|
| 癌症类型 | Cervical Carcinoma |
| 细胞形态 | Adherent |
| 传代比率 | 1/5, 2days |
| 完全培养基 | MEM + 10% FBS |
| 冻存培养基 | 70%完全培养基+ 20% FBS+ 10% DMSO |
* 仅供科研使用,不适用于人体或动物,包括临床、治疗或诊断用途。
| Loci | 送检细胞STR信息 送检细胞名: HeLa | 细胞库细胞STR信息 细胞库细胞名: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* 该细胞系与收录于ATCC, DSMZ, JCRB 和 RIKEN数据库的细胞系STR数据匹配。
结论:该细胞 STR 鉴定正确。
结论:该细胞 STR 鉴定正确。
* 研究用途免责声明:本内容基于公开的研究数据、生物信息学资源及计算分析生成,仅供研究参考。
相关研究文献
致病 ALS 基因影响 MHC II 类抗原呈递途径。
IF=9.1
Proceedings of the National Academy of Sciences of the United States of America
该KO模型可能有助于:
- 研究MHC II类抗原呈递在神经退行性疾病(如ALS)中的作用;
- 研究ALS致病基因对免疫相关通路的影响;
- 验证CIITA介导的抗原呈递转录调控的功能;
- 探索神经元应激与适应性免疫反应之间的相互作用;
- 筛选疾病相关细胞环境中MHC II类表达的调节因子。